Literature DB >> 16899484

Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis.

G Senol1, O F Erer, Y A Yalcin, M Coskun, A T Gündüz, C Biçmen, M Ertas, S A Ozkan.   

Abstract

Several ELISA tests based on mycobacterial antigens have been used for the rapid diagnosis of tuberculosis (TB), although demonstration of Mycobacterium tuberculosis in a smear or culture is the most reliable method. In the present study, the diagnostic value of 16-kDa and 38-kDa mycobacterial antigens was investigated in patients who were diagnosed with tuberculosis by clinical and/or bacteriological findings in Turkey. The PATHOZYME-TB Complex Plus commercial ELISA kit was used for measuring immunoglobulin G against 38-kDa and 16-kDa recombinant antigens. Humoral immune response was analysed in a group of 179 TB patients (143 smear-positive, 19 smear-negative, eight lymphadenitis and nine pleuritis), 15 inactive TB cases and in control groups consisting of 40 healthy volunteers and 20 subjects with pulmonary diseases other than TB. The sensitivity, specifity, positive predictive value and negative predictive value of the test were determined at 52.5%, 93.3%, 95.9% and 39.7%, respectively in TB cases. Antibodies were detected at above cut-off level in three (20%) out of 15 subjects with inactive TB. In conclusion, the ELISA test has a very good specifity and an acceptable sensitivity and positive predictive value. It is thought that it could be used in combination with other methods to increase diagnostic accuracy, especially for culture-negative tuberculosis cases, which are difficult to diagnose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899484     DOI: 10.1183/09031936.06.00042706

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  Humoral immune responses against the Mycobacterium tuberculosis 38-kilodalton, MTB48, and CFP-10/ESAT-6 antigens in tuberculosis.

Authors:  Xueqiong Wu; Yourong Yang; Junxian Zhang; Bangying Li; Yan Liang; Chuiying Zhang; Mei Dong; Hongbing Cheng; Jufang He
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

Review 2.  Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis.

Authors:  Karen R Steingart; Laura L Flores; Nandini Dendukuri; Ian Schiller; Suman Laal; Andrew Ramsay; Philip C Hopewell; Madhukar Pai
Journal:  PLoS Med       Date:  2011-08-09       Impact factor: 11.069

3.  Diagnostic performance of commercially available enzyme-linked immunosorbent assay kit in the diagnosis of extrapulmonary tuberculosis.

Authors:  Manimuthu Mani Sankar; Veena Balooni; Jitendra Singh; Sarman Singh
Journal:  J Lab Physicians       Date:  2013-01

4.  Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Caiqin Zhang; Xiaoqin Song; Yong Zhao; Hai Zhang; Shanmin Zhao; Fengfeng Mao; Bing Bai; Shaoping Wu; Changhong Shi
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

Review 5.  Current issues on molecular and immunological diagnosis of tuberculosis.

Authors:  Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

6.  PCR-Based Evaluation of Tuberculous Endometritis in Infertile Women of North India.

Authors:  Monika D Kohli; Bimota Nambam; Sagar S Trivedi; Banke L Sherwal; Sarika Arora; Anju Jain
Journal:  J Reprod Infertil       Date:  2011-01

7.  Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis.

Authors:  Parvaneh Baghaei; Payam Tabarsi; Hojat Sabour; Shokoufeh Dehghani; Majid Marjani; Masoud Shamaei; Ali Jabbari; Majid Valiollahpour Amiri; Ali Akbar Velayati
Journal:  Tanaffos       Date:  2011

8.  Assessment of Extrapulmonary Tuberculosis in Two Provinces of Turkey.

Authors:  Dursun Tatar; Gunes Senol; Serpil Alptekin; Ebru Gunes; Mert Aydin; Ozdal Gunes
Journal:  Iran J Public Health       Date:  2016-03       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.